Neos Therapeutics, Inc. 4
4 · Neos Therapeutics, Inc. · Filed Jun 1, 2016
Insider Transaction Report
Form 4
Martens Juergen
Chief Tech/Operations Officer
Transactions
- Award
Stock Option (Right to Buy)
2016-06-01+150,000→ 150,000 totalExercise: $10.96Exp: 2026-05-31→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]This stock option vests in equal annual installments over a four-year period which began on May 31, 2016.